News
Media
Multimedia Series
Conferences
Partners
CME/CE
Resources
Advisory Board
Subscribe

Spotlight -

This Year In Medicine 2025

Andrew Cutler, MD

Articles by Andrew Cutler, MD

Role of Patient Engagement in MDD Treatment

ByAndrew Cutler, MD,Gregory Mattingly, MD,Sagar V Parikh, MD, FRCPC

December 23rd 2022

Sagar V. Parikh, MD, FRCPC, leads a discussion on patient engagement and shared decision-making in treatment selection in MDD.

Treatment Selection for MDD

ByAndrew Cutler, MD,Gregory Mattingly, MD,Sagar V Parikh, MD, FRCPC

December 23rd 2022

Drs Andrew J. Cutler, Gregory Mattingly, and Sagar V. Parikh share their approach to treatment selection for patients with MDD.

Final Thoughts on Management of ADHD

ByTheresa R. Cerulli, MD,Andrew Cutler, MD,Alice Mao, MD,Birgit H. Amann, MD,Michael Feld, MD

December 21st 2022

ADHD experts share their final thoughts on the treatment and management of ADHD.

Unmet Needs in Management of ADHD

ByTheresa R. Cerulli, MD,Andrew Cutler, MD,Alice Mao, MD,Birgit H. Amann, MD,Michael Feld, MD

December 21st 2022

Drs Feld, Cutler, Mao, and Amann discuss unmet needs in the management of ADHD.

Relationship Between Depression and Other Health Conditions

ByAndrew Cutler, MD,Gregory Mattingly, MD,Sagar V Parikh, MD, FRCPC

December 16th 2022

Andrew J. Cutler, MD; Gregory Mattingly, MD; and Sagar V. Parikh, MD, FRCPC, discuss the connection between depression and other health conditions, as well as the economic impact of major depressive disorder [MDD].

Prevalence and Risk Factors for Major Depressive Disorder (MDD)

ByAndrew Cutler, MD,Gregory Mattingly, MD,Sagar V Parikh, MD, FRCPC

December 16th 2022

Andrew J. Cutler, MD; Gregory Mattingly, MD; and Sagar V. Parikh, MD, FRCPC, review trends in the prevalence of major depressive disorder (MDD) in the US, and the impact of the COVID-19 pandemic on MDD trends.

Access to ADHD Treatments

ByTheresa R. Cerulli, MD,Andrew Cutler, MD,Alice Mao, MD,Birgit H. Amann, MD,Michael Feld, MD

December 14th 2022

ADHD experts discuss strategies for improving access to ADHD medications for their patients.

Emerging Treatments for Adults With ADHD

ByTheresa R. Cerulli, MD,Andrew Cutler, MD,Alice Mao, MD,Birgit H. Amann, MD,Michael Feld, MD

December 14th 2022

ADHD experts discuss novel treatments and unmet needs in pediatric and adult patients.

Pharmacological Properties and Efficacy Data of Amphetamine XR Oral Tablets

ByTheresa R. Cerulli, MD,Andrew Cutler, MD,Alice Mao, MD,Birgit H. Amann, MD,Michael Feld, MD

December 7th 2022

Drs Cerulli and Cutler discuss the data and pharmacological properties of amphetamine XR oral tablets.

Amphetamine XR Oral Tablets in Clinical Practice

ByTheresa R. Cerulli, MD,Andrew Cutler, MD,Alice Mao, MD,Birgit H. Amann, MD,Michael Feld, MD

December 7th 2022

Panelists discuss the use of amphetamine XR oral tablets in their practice and for which patients they’re using them.

Recent FDA Approvals for ADHD Treatment

ByTheresa R. Cerulli, MD,Andrew Cutler, MD,Alice Mao, MD,Birgit H. Amann, MD,Michael Feld, MD

November 30th 2022

Birgit H. Amann, MD, PLLC, discusses 2 recently approved treatment options for ADHD: amphetamine XR oral tablets and viloxazine.

Individualizing ADHD Treatment for Different Patient Populations

ByTheresa R. Cerulli, MD,Andrew Cutler, MD,Alice Mao, MD,Birgit H. Amann, MD,Michael Feld, MD

November 30th 2022

Panelists discuss the importance of choosing treatments that are individualized to their patients.

Choosing Between Different ADHD Formulations

ByTheresa R. Cerulli, MD,Andrew Cutler, MD,Alice Mao, MD,Birgit H. Amann, MD,Michael Feld, MD

November 23rd 2022

Psychiatrists share their approach to choosing between different ADHD medications and formulations.

Different Formulations of ADHD Medications

ByTheresa R. Cerulli, MD,Andrew Cutler, MD,Alice Mao, MD,Birgit H. Amann, MD,Michael Feld, MD

November 23rd 2022

Dr Feld highlights several formulations that are available to treat ADHD.

Treatment Options for ADHD

ByTheresa R. Cerulli, MD,Andrew Cutler, MD,Alice Mao, MD,Birgit H. Amann, MD,Michael Feld, MD

November 16th 2022

Dr Cutler shares treatment options for ADHD.

Treatment Goals and Treatment Selection in ADHD

ByTheresa R. Cerulli, MD,Andrew Cutler, MD,Alice Mao, MD,Birgit H. Amann, MD,Michael Feld, MD

November 16th 2022

Dr Amann and other experts discuss importance of carefully weighing patient and parent expectations and goals when choosing treatment.

Factors Guiding Treatment Selection in ADHD

ByTheresa R. Cerulli, MD,Andrew Cutler, MD,Alice Mao, MD,Birgit H. Amann, MD,Michael Feld, MD

November 9th 2022

Drs Cerulli and Cutler discuss factors guiding treatment selection in ADHD.

Comorbidities in Patients with ADHD

ByTheresa R. Cerulli, MD,Andrew Cutler, MD,Alice Mao, MD,Birgit H. Amann, MD,Michael Feld, MD

November 9th 2022

ADHD experts discuss their approaches to management of ADHD in patients with comorbidities.

Place of Telemedicine in ADHD

ByTheresa R. Cerulli, MD,Andrew Cutler, MD,Alice Mao, MD,Birgit H. Amann, MD,Michael Feld, MD

November 2nd 2022

Psychiatrists share how they have incorporated telemedicine in the management of ADHD in their clinics.

Clinical Burden of ADHD and Impact on Quality of Life

ByTheresa R. Cerulli, MD,Andrew Cutler, MD,Alice Mao, MD,Birgit H. Amann, MD,Michael Feld, MD

November 2nd 2022

Panelists share clinical burden of ADHD and how it impacts pediatric, adolescent and adult populations.

Underdiagnosis of Adult ADHD

ByTheresa R. Cerulli, MD,Andrew Cutler, MD,Alice Mao, MD,Birgit H. Amann, MD,Michael Feld, MD

October 26th 2022

ADHD experts discuss presentation and underdiagnosis of ADHD in adults.

Attention-Deficit/Hyperactivity Disorders in Pediatric and Adult Populations

ByTheresa R. Cerulli, MD,Andrew Cutler, MD,Alice Mao, MD,Birgit H. Amann, MD,Michael Feld, MD

October 26th 2022

Drs Cerulli, Feld, Cutler, Mao, and Amann discuss prevalence and presentation of ADHD in pediatric, adolescent and adult populations.

Trending on HCPLive

FDA Approves Olezarsen (Tryngolza) for Severe Hypertriglyceridemia

The United Airway in Practice: Rhinitis, Nasal Polyps, and NERD Are Drivers of Asthma Burden

The Medical Sisterhood: The Strength Nobody Talks About, with Saakshi Khattri, MD

Moving the Needle in Medicine: Heart Failure, Human Connection, and Career Fulfillment, With Anu Lala, MD

Delgocitinib Approval Fills a Long-Standing Gap in Chronic Hand Eczema Treatment